Why Is Tesla Stock Falling?
Tesla stock reached an all-time high of $479.86 on December…
Buy
56
XTNT Quote, Financials, Valuation and Earnings
Last price:
$0.60
Seasonality move
:
-0.9%
Day range:
$0.56 - $0.62
52-week range:
$0.33 - $1.30
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.70x
P/B ratio:
1.82x
Volume:
121.7K
Avg. volume:
56.6K
1-year change:
-43.53%
Market cap:
$83.2M
Revenue:
$91.3M
EPS (TTM):
-$0.13
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Xtant Medical Holdings has 275.91% upside to fair value with a price target of -- per share.
XTNT vs. S&P 500
-
Over the past 5 trading days, Xtant Medical Holdings has overperformed the S&P 500 by 1.7% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Xtant Medical Holdings does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Xtant Medical Holdings has grown year-over-year revenues for 11 quarters straight. In the most recent quarter Xtant Medical Holdings reported revenues of $27.9M.
Earnings Growth
-
Xtant Medical Holdings has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Xtant Medical Holdings reported earnings per share of -$0.04.
Enterprise value:
111.4M
EV / Invested capital:
--
Price / LTM sales:
0.70x
EV / EBIT:
--
EV / Revenue:
0.98x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-6.45x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
55.58x
Gross Profit (TTM):
$69.3M
Return On Assets:
-18.59%
Net Income Margin (TTM):
-15.45%
Return On Equity:
-35.98%
Return On Invested Capital:
-22.96%
Operating Margin:
-13.52%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $56.7M | $78.5M | $113.9M | $25M | $27.9M | |
| Gross Profit | $31.5M | $46.6M | $69.3M | $15.3M | $16.3M | |
| Operating Income | -$6.9M | -$8.1M | -$14M | -$3.4M | -$3.8M | |
| EBITDA | -$5.7M | $5.6M | -$8.9M | $8.6M | -$2.7M | |
| Diluted EPS | -$0.11 | $0.01 | -$0.13 | $0.07 | -$0.04 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $32.4M | $45.6M | $45.1M | $64.1M | $71.4M | |
| Total Assets | $42.4M | $55.8M | $56M | $92M | $98.9M | |
| Current Liabilities | $9.3M | $10.4M | $11.4M | $21.9M | $33.7M | |
| Total Liabilities | $90.4M | $23.2M | $23.3M | $37.3M | $53.2M | |
| Total Equity | -$48M | $32.6M | $32.8M | $54.7M | $45.7M | |
| Total Debt | $79.6M | $15.2M | $12.7M | $21.2M | $34.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$2.6M | -$10.9M | -$13.5M | -$3.8M | -$1.7M | |
| Cash From Investing | -$1.7M | -$22.9M | -$5.5M | -$4.7M | -$2M | |
| Cash From Financing | $3.4M | $25M | $17.3M | $12.8M | $5.3M | |
| Free Cash Flow | -$4.6M | -$12.4M | -$17.3M | -$4.1M | -$3.8M | |
XTNT
Sector
Market Cap
$83.2M
$43.4M
Price % of 52-Week High
46.05%
48.26%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.75%
1-Year Price Total Return
-43.53%
-34.26%
Beta (5-Year)
0.361
0.749
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$0.59
200-day SMA
Sell
Level
$0.61
Bollinger Bands (100)
Buy
Level
0.43 - 0.61
Chaikin Money Flow
Sell
Level
-202.9M
20-day SMA
Buy
Level
$0.58
Relative Strength Index (RSI14)
Buy
Level
57.34
ADX Line
Buy
Level
39.19
Williams %R
Neutral
Level
-42.0294
50-day SMA
Buy
Level
$0.49
MACD (12, 26)
Buy
Level
0.03
25-day Aroon Oscillator
Buy
Level
64
On Balance Volume
Neutral
Level
457.5M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.0617)
Buy
CA Score
(Annual)
Level (0.3898)
Sell
Beneish M-Score
(Annual)
Level (-0.5477)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-6.6409)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
Stock Forecast FAQ
In the current month, XTNT has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The XTNT average analyst price target in the past 3 months is --.
-
Where Will Xtant Medical Holdings Stock Be In 1 Year?
According to analysts, the consensus estimate is that Xtant Medical Holdings share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Xtant Medical Holdings?
Analysts are divided on their view about Xtant Medical Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Xtant Medical Holdings is a Sell and believe this share price will drop from its current level to --.
-
What Is Xtant Medical Holdings's Price Target?
The price target for Xtant Medical Holdings over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is XTNT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Xtant Medical Holdings is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of XTNT?
You can purchase shares of Xtant Medical Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Xtant Medical Holdings shares.
-
What Is The Xtant Medical Holdings Share Price Today?
Xtant Medical Holdings was last trading at $0.60 per share. This represents the most recent stock quote for Xtant Medical Holdings. Yesterday, Xtant Medical Holdings closed at $0.60 per share.
-
How To Buy Xtant Medical Holdings Stock Online?
In order to purchase Xtant Medical Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is DoorDash a Buy, Sell or Hold?
Gig economy food delivery service DoorDash (NASDAQ:DASH) has been running…
Is Clorox’s Dividend Worth It?
Clorox (NYSE:CLX) is the parent company of some of the…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
61
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 116x
Sell
47
Is MSFT Stock a Buy?
Market Cap: $3T
P/E Ratio: 35x
Alerts
Buy
87
PCOR alert for Feb 15
Procore Technologies [PCOR] is up 16.3% over the past day.
Buy
54
DKNG alert for Feb 15
DraftKings [DKNG] is up 15.24% over the past day.
Sell
30
TWLO alert for Feb 15
Twilio [TWLO] is down 15.01% over the past day.
